SAD/MAD Services & Products

  1. Early-Phase Metabolic Development
    ICON’s consultancy services advise on clinical pharmacology study designs based on preclinical data – including potential use of surrogate markers and pharmacodynamic models, validation of those markers and models, clear objective setting and flexible protocol design.
  2. First In Human Clinical Trials
    Timely and accurate data regarding the safety and efficacy of drug is critical for success at every stage of drug discovery and development.